BlackRock, Inc. 13D and 13G filings for Bristol-Myers Squibb Company:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Bristol-Myers Squibb Company BMY | BlackRock Inc. BLK | 143,574,230 7.100% | -24,523,997 (-14.59%) | Filing |
| 2024-01-25 4:59 pm Sale | 2023-12-31 | 13G | Bristol-Myers Squibb Company BMY | BlackRock Inc. BLK | 168,098,227 8.300% | -4,622,150 (-2.68%) | Filing |
| 2023-02-07 2:10 pm Purchase | 2022-12-31 | 13G | Bristol-Myers Squibb Company BMY | BlackRock Inc. BLK | 172,720,377 8.100% | 3,493,671 (+2.06%) | Filing |
| 2022-01-31 5:59 pm Sale | 2021-12-31 | 13G | Bristol-Myers Squibb Company BMY | BlackRock Inc. BLK | 169,226,706 7.600% | -3,238,098 (-1.88%) | Filing |